Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $727 - $904
3 Added 0.28%
1,080 $265,000
Q2 2022

Aug 11, 2022

SELL
$224.73 - $338.64 $4,045 - $6,095
-18 Reduced 1.64%
1,077 $267,000
Q1 2022

May 13, 2022

SELL
$277.25 - $366.29 $25,229 - $33,332
-91 Reduced 7.67%
1,095 $363,000
Q4 2021

Mar 11, 2022

BUY
$300.63 - $371.35 $22,547 - $27,851
75 Added 6.75%
1,186 $426,000
Q3 2021

Nov 10, 2021

SELL
$310.19 - $376.2 $342,139 - $414,948
-1,103 Reduced 49.82%
1,111 $362,000
Q1 2021

Apr 21, 2021

BUY
$285.92 - $355.13 $369,122 - $458,472
1,291 Added 139.87%
2,214 $706,000
Q4 2020

Feb 12, 2021

SELL
$251.88 - $324.2 $280,342 - $360,834
-1,113 Reduced 54.67%
923 $299,000
Q3 2020

Oct 30, 2020

SELL
$255.22 - $317.0 $249,605 - $310,026
-978 Reduced 32.45%
2,036 $564,000
Q2 2020

Aug 12, 2020

SELL
$141.4 - $257.09 $82,012 - $149,112
-580 Reduced 16.14%
3,014 $728,000
Q1 2020

May 13, 2020

SELL
$130.51 - $196.01 $81,699 - $122,702
-626 Reduced 14.83%
3,594 $522,000
Q4 2019

Feb 12, 2020

SELL
$159.31 - $223.54 $21,825 - $30,624
-137 Reduced 3.14%
4,220 $720,000
Q3 2019

Nov 13, 2019

SELL
$175.89 - $279.23 $314,315 - $498,984
-1,787 Reduced 29.09%
4,357 $775,000
Q2 2019

Aug 14, 2019

SELL
$250.96 - $284.94 $6,524 - $7,408
-26 Reduced 0.42%
6,144 $1.6 Million
Q1 2019

May 15, 2019

SELL
$276.39 - $362.25 $46,709 - $61,220
-169 Reduced 2.67%
6,170 $1.76 Million
Q4 2018

Feb 13, 2019

SELL
$281.08 - $444.25 $2.59 Million - $4.09 Million
-9,214 Reduced 59.24%
6,339 $2.06 Million
Q3 2018

Nov 13, 2018

BUY
$354.53 - $449.75 $332,194 - $421,415
937 Added 6.41%
15,553 $6.99 Million
Q2 2018

Aug 13, 2018

BUY
$278.07 - $446.21 $4.06 Million - $6.52 Million
14,616 New
14,616 $5.98 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.